1. Home
  2. RGEN vs WAL Comparison

RGEN vs WAL Comparison

Compare RGEN & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • WAL
  • Stock Information
  • Founded
  • RGEN 1981
  • WAL 1994
  • Country
  • RGEN United States
  • WAL United States
  • Employees
  • RGEN N/A
  • WAL N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • WAL Major Banks
  • Sector
  • RGEN Health Care
  • WAL Finance
  • Exchange
  • RGEN Nasdaq
  • WAL Nasdaq
  • Market Cap
  • RGEN 7.6B
  • WAL 8.8B
  • IPO Year
  • RGEN N/A
  • WAL 2005
  • Fundamental
  • Price
  • RGEN $156.55
  • WAL $83.58
  • Analyst Decision
  • RGEN Buy
  • WAL Strong Buy
  • Analyst Count
  • RGEN 12
  • WAL 16
  • Target Price
  • RGEN $187.44
  • WAL $94.31
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • WAL 1.1M
  • Earning Date
  • RGEN 02-19-2025
  • WAL 01-27-2025
  • Dividend Yield
  • RGEN N/A
  • WAL 1.83%
  • EPS Growth
  • RGEN N/A
  • WAL N/A
  • EPS
  • RGEN N/A
  • WAL 6.47
  • Revenue
  • RGEN $633,513,000.00
  • WAL $2,910,700,000.00
  • Revenue This Year
  • RGEN $2.28
  • WAL N/A
  • Revenue Next Year
  • RGEN $9.88
  • WAL $8.86
  • P/E Ratio
  • RGEN N/A
  • WAL $12.83
  • Revenue Growth
  • RGEN N/A
  • WAL 12.72
  • 52 Week Low
  • RGEN $113.50
  • WAL $53.75
  • 52 Week High
  • RGEN $211.13
  • WAL $98.10
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • WAL 46.40
  • Support Level
  • RGEN $149.15
  • WAL $77.12
  • Resistance Level
  • RGEN $160.64
  • WAL $87.84
  • Average True Range (ATR)
  • RGEN 5.96
  • WAL 2.56
  • MACD
  • RGEN 0.91
  • WAL -0.15
  • Stochastic Oscillator
  • RGEN 79.57
  • WAL 60.26

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking. Corporate & Other.

Share on Social Networks: